SI

Sofinnova Investments Portfolio holdings

AUM $1.47B
1-Year Est. Return 17.43%
This Quarter Est. Return
1 Year Est. Return
+17.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.33B
AUM Growth
-$38.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1 +$68M
2 +$50.6M
3 +$31.7M
4
PTCT icon
PTC Therapeutics
PTCT
+$29.5M
5
IDYA icon
IDEAYA Biosciences
IDYA
+$25.4M

Top Sells

1 +$63.9M
2 +$42.7M
3 +$39.8M
4
AXSM icon
Axsome Therapeutics
AXSM
+$36.9M
5
BSX icon
Boston Scientific
BSX
+$31M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRA icon
1
Natera
NTRA
$26.4B
$219M 14.32%
1,550,280
SYK icon
2
Stryker
SYK
$146B
$111M 7.26%
298,567
+182,562
VERA icon
3
Vera Therapeutics
VERA
$1.86B
$67.1M 4.38%
2,793,987
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$8.4B
$63.3M 4.14%
510,050
+5,857
MDT icon
5
Medtronic
MDT
$120B
$50.6M 3.3%
+562,992
ALNY icon
6
Alnylam Pharmaceuticals
ALNY
$60.7B
$47.6M 3.11%
176,181
+66,024
GILD icon
7
Gilead Sciences
GILD
$150B
$46.9M 3.07%
418,900
-355,327
LLY icon
8
Eli Lilly
LLY
$740B
$43.6M 2.85%
52,800
+38,436
IDYA icon
9
IDEAYA Biosciences
IDYA
$2.56B
$43M 2.81%
2,622,192
+1,553,102
SLNO icon
10
Soleno Therapeutics
SLNO
$3.41B
$34.6M 2.26%
484,471
-272,777
AVBP icon
11
ArriVent BioPharma
AVBP
$755M
$31.4M 2.05%
1,696,752
PTCT icon
12
PTC Therapeutics
PTCT
$5.27B
$29.5M 1.93%
+579,339
SNDX icon
13
Syndax Pharmaceuticals
SNDX
$1.17B
$28M 1.83%
2,275,223
+1,616,596
DXCM icon
14
DexCom
DXCM
$27.6B
$27M 1.77%
395,975
+105,765
BBIO icon
15
BridgeBio Pharma
BBIO
$10.4B
$25.4M 1.66%
+734,227
REPL icon
16
Replimune Group
REPL
$687M
$24.2M 1.58%
2,479,939
-669,583
RYTM icon
17
Rhythm Pharmaceuticals
RYTM
$7.34B
$23.7M 1.55%
446,839
+49,411
INSM icon
18
Insmed
INSM
$33.7B
$23.2M 1.52%
304,254
+47,973
BPMC
19
DELISTED
Blueprint Medicines
BPMC
$23.1M 1.51%
+261,039
BMY icon
20
Bristol-Myers Squibb
BMY
$89.2B
$22.7M 1.48%
+371,497
INCY icon
21
Incyte
INCY
$17.8B
$21.7M 1.42%
357,800
-166,467
ANAB icon
22
AnaptysBio
ANAB
$981M
$21.6M 1.41%
1,160,033
+1,027,106
SRPT icon
23
Sarepta Therapeutics
SRPT
$2.39B
$20.9M 1.37%
327,618
-101,153
AKRO icon
24
Akero Therapeutics
AKRO
$4.31B
$20.6M 1.35%
+510,020
AXSM icon
25
Axsome Therapeutics
AXSM
$6.46B
$20.4M 1.34%
175,317
-316,409